Active · per the CBE, 17 November 2026

Neuraxpharm Belgium

BE0793136336

Rechtspersoon Private limited company 1 establishment

Neuraxpharm Belgium is a wholesaler in Sint-Joost-ten-Node. Private Limited, started on 28 October 2022, 1 establishment.

Sint-Lazaruslaan 4/10, 1210 Sint-Joost-ten-Node

Behind the company: Maximilian VON WULFING, Pierre Hervé BRUN.

Active for

4 year

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Negative equity NBB

    More debt than assets in 4 of the last 4 fiscal years.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

  • Tight liquidity NBB

    Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.

  • Busy address KBO

    26 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

Neuraxpharm Belgium from Sint-Joost-ten-Node, company number BE0793136336, closed financial year 2025 with a result of € -363,597 after tax. For that financial year Neuraxpharm Belgium recorded revenue of € 3.7 million and equity of € -958,982. Compared with financial year 2024, the result moved from € -143,209 to € -363,597. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 27, 2026.

What it is worth Caution

€ -958,982

▼ € 363,597 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -363,597

▼ 154 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 587,196

▲ 61% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -963,982.

People and assets in 2025

Full-time equivalents

4.8

▲ 4.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 687,434

▲ € 555,809 vs 2024

€ 143,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 11,013

▲ 85% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3.5 million

▲ 56% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 495,207

▲ 122% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
2022202320242025Change 2024 → 2025
Revenue - - - € 3,717,080
Gross margin € -20,197 € -193,684 € -34,758 € 813,039 ▲ € 847,796
Profit after taxes € -20,197 € -436,979 € -143,209 € -363,597 ▼ € 220,388
Equity € -15,197 € -452,176 € -595,385 € -958,982 ▼ € 363,597
Total debts € 20,810 € 1,461,654 € 2,480,180 € 4,065,666 ▲ 64%
Cash € 5,000 € 94,307 € 364,299 € 587,196 ▲ 61%
Retained profit € -20,197 € -457,176 € -600,385 € -963,982 ▼ € 363,597
Balance sheet total € 5,614 € 1,009,478 € 1,884,796 € 3,106,684 ▲ 65%
Employees (FTE) - - 0.7 4.8 ▲ 4.1

By revenue, Neuraxpharm Belgium ranks 67th of 74 companies with main activity “Groothandel in farmaceutische en medische artikelen” in the Brussels Region that publish figures (fiscal year 2025).

Key figures of Neuraxpharm Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Neuraxpharm Belgium?

What happened at Neuraxpharm Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 363,597. filed late Source: NBB ↗
  • Pierre Hervé BRUN became a director. NBB
  • Michaël LUGEZ stepped down as director. NBB
  • Michaël LUGEZ became a director. NBB
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Sint-Joost-ten-Node. KBO
  • Maximilian VON WULFING became a director. NBB

In short

From € 20,197 loss in 2022 to € 363,597 loss in 2025.

Paid € 118 in corporate taxes since 2022.

On average € 169,400 of value added per employee in 2025.

Management

Neuraxpharm Belgium

Behind Neuraxpharm Belgium are Maximilian VON WULFING and Pierre Hervé BRUN. The shares are held by Neuraxpharm Arzneimittel (100%).

Directors

According to the 2025 annual accounts

Maximilian VON WULFING

Director

since 2022

Pierre Hervé BRUN

Director

since 2025

Michaël LUGEZ

Director

since 2024 · until 2025

Shareholders

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Lazaruslaan 4/10

1210 Sint-Joost-ten-Node

2.337.692.179

Sint-Lazaruslaan 4-10 ET6

1210 Sint-Joost-ten-Node

Active since 28 October 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in the Brussels Region

Same main activity (Groothandel in farmaceutische en medische artikelen), 283 active companies in the Brussels Region, largest first.

UCB PHARMA

€ 4.6 billion revenue · 2025 · Anderlecht

PHOENIX Pharma Belgium

€ 1.1 billion revenue · 2023 · Sint-Lambrechts-Woluwe

CENTRE EUROPEEN DE REPARTITION PHARMACEUTIQUE

€ 580.7 million revenue · 2025 · Anderlecht

MSD BELGIUM

€ 506.5 million revenue · 2025 · Watermaal-Bosvoorde

ANSELL HEALTHCARE EUROPE

€ 472.7 million revenue · 2025 · Anderlecht

ROCHE

€ 448.8 million revenue · 2025 · Anderlecht

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • Neuraxpharm Arzneimittel GmbH(fondateur) 100%

Details

Company number
0793.136.336
VAT number
BE 0793.136.336
Registered office
Sint-Lazaruslaan 4/10, 1210 Sint-Joost-ten-Node
Names & denominations
Neuraxpharm Belgium
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
28 October 2022
Peppol
Active · Active since 27 Nov 2025
Activities · NACE

Groothandel in farmaceutische en medische artikelen

Frequently asked questions

What does Neuraxpharm Belgium do?
Neuraxpharm Belgium is a wholesaler in Sint-Joost-ten-Node. Private Limited, started on 28 October 2022, 1 establishment.
What is the address of Neuraxpharm Belgium?
The registered office of Neuraxpharm Belgium is located at Sint-Lazaruslaan 4/10, 1210 Sint-Joost-ten-Node.
Is Neuraxpharm Belgium still active?
Yes. According to the CBE (17 November 2026) Neuraxpharm Belgium is active, legal situation “Normale toestand”, started on 28 October 2022.
Is Neuraxpharm Belgium registered on Peppol?
Yes, Neuraxpharm Belgium is registered on the Peppol network with ID 0208:0793136336.
What is the enterprise number of Neuraxpharm Belgium?
The enterprise number of Neuraxpharm Belgium is BE0793136336.
When was Neuraxpharm Belgium founded?
Neuraxpharm Belgium was founded on 28 October 2022.